205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-17.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-66.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-101.44%
Negative EBIT growth while ADI is at 4.55%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-101.44%
Negative operating income growth while ADI is at 4.55%. Joel Greenblatt would press for urgent turnaround measures.
-63.79%
Negative net income growth while ADI stands at 60.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-65.00%
Negative EPS growth while ADI is at 455.56%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-65.00%
Negative diluted EPS growth while ADI is at 455.56%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.12%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.12%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
3.02%
Dividend growth of 3.02% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-74.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1004.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
24.33%
Similar 10Y revenue/share CAGR to ADI's 24.60%. Walter Schloss might see both firms benefiting from the same long-term demand.
24.33%
5Y revenue/share CAGR similar to ADI's 24.60%. Walter Schloss might see both companies benefiting from the same mid-term trends.
13.75%
3Y revenue/share CAGR at 50-75% of ADI's 25.42%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
192.70%
10Y net income/share CAGR of 192.70% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
192.70%
Net income/share CAGR of 192.70% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-83.61%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.60%
3Y dividend/share CAGR of 76.60% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-2.85%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.52%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.34%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.80%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-3.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
7.50%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.